Is Haemonetics Corporation overvalued?

Haemonetics Corporation (HAE) looks undervalued — trading about 24% below its fair value.

Undervalued

Price

$105.30

Fair value

$131.01

Current P/E

21.2

Normal P/E

26.4

Market cap

$4.79B

Dividend yield

0.0%

Return on equity

11.3%

Sector

Healthcare

Fair value compares HAE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks